top of page
Adjust the brightnes.png

Nucleic acids drive
the evolution of medicine.

TKG Therapeutics, Inc.

Our DNA

Driving medical progress with nucleic acid technology.

 - instilling hope and confidence worldwide.

Pioneering global medical innovation through advanced nucleic acid therapeutics and synthesis technologies.

Drug Discovery

We are pioneering a new class of cancer therapeutics.
Not siRNA. Not antisense oligonucleotides.
Driven by novel nucleic acid technology, we are shaping the next evolution in cancer medicine.

more

Synthesis Technology

We are developing novel synthesis technologies to unlock the full potential of nucleic acids in medicine.
Our innovative approach is reshaping the landscape of nucleic acid therapeutics.

more

Core
Technologies

ICCサミット KYOTO 2026

ディープテック・カタパルト 第2位

Team

004.jpg

Makoto Yamamoto / Ph.D.
Chief Executive Officer

岡本先生（背景なし）.png

Terumitsu Okamoto
/ Ph.D. in Engineering
Founder / Director

kinoshita2_edited.jpg

Taro Kinoshita
Director

Contact

Entrepreneur Lab, South Research Building
The University of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8485, Japan

inquiry

Contact

TKG Therapeutics, Inc.

© 2025-2026 TKG Therapeutics, Inc.

bottom of page